每周股票复盘：丰原药业（000153）拟增资5300万元参与基金

Core Viewpoint - Fengyuan Pharmaceutical (000153) has experienced a decline in stock price, closing at 6.41 yuan, down 2.14% from the previous week, with a current market capitalization of 2.914 billion yuan [1] Company Announcements - The company will hold its 10th Board of Directors' fourth (temporary) meeting on December 29, 2025, to review the proposal for increasing capital to Hefei Hongfeng Equity Investment Fund Center (Limited Partnership) [2] - Fengyuan Pharmaceutical plans to increase its investment by 53 million yuan, raising its total contribution to 203 million yuan, which will account for 47.21% of the fund's total subscribed capital [2] - Following this capital increase, the fund's size will grow from 310 million yuan to 430 million yuan [2]